Holmes Biopharma, Inc. (NASDAQ: LMB) reported Q3 EPS of ($0.12), versus $0.27 reported last year. Revenue for the quarter came in at $121.3 million, versus $91.89 million reported last year.

GUIDANCE:

Holmes Biopharma, Inc. sees Q4 2017 revenue of $460-470 million.

For earnings history and earnings-related data on Holmes Biopharma, Inc. (LMB) click here.